Delivery Order SPE2DB22D1103-SPE2DB24FTNP4

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,961.25 firm fixed-price delivery order is for the supply of 4566789424 - Duloxetine HCL DR 40 MG capsules, with a completion date of December 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Duloxetine HCL DR 40 mg capsules. The contract is a delivery order with a firm fixed price of $1,342.68 and an ultimate completion date of December 20, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order for the supply of Duloxetine HCl DR 40 mg capsules. The award, valued at $1,483.26, has an ultimate completion date of May 14, 2025 and is not set aside for any particular type of business. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of Duloxetine HCL DR 60 MG capsules, with a firm fixed price of $1,305.18 and a completion date of June 26, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,576.96 under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,566,555,940 units of the medication Duloxetine HCL DR 40 MG capsules. This contract supports the procurement of essential pharmaceutical products and medical supplies for military healthcare programs,...
This federal contract award is for the delivery of Duloxetine HCL DR 40 mg capsules, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,838.53 and is a firm-fixed-price delivery order. The award is not associated with a set-aside program. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,785.26 firm-fixed-price delivery order is for the supply of 1,000 units of the medication Duloxetine HCL DR 60 MG CAP. The contract has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVQ42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,414.79 firm fixed-price delivery order is for the supply of 4,568,204,795 units of Duloxetine HCL DR 30 mg capsules. The contract has an ultimate completion date of May 12, 2025 and was awarded on May 9, 2025. This award is not designated as a set-aside contract....
This federal contract award, valued at $1,660.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of 4564704255 - Duloxetine HCL DR 40 MG capsules, with a completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Duloxetine HCl DR 40 mg capsules. The contract has a ceiling value of $1,022.54 and a performance period extending through June 18, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTNP4
    Delivery Order

This federal contract award, valued at $4,054.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Duloxetine HCL DR 40 MG capsules, a generic medication used to treat various conditions.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 10:06 AM